• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

MI-2

CAS No. 1047953-91-2

MI-2 ( MI 2 | MI2 )

产品货号. M10236 CAS No. 1047953-91-2

MI-2(MALT1 抑制剂)是一种选择性、不可逆的 MALT1 副半胱天冬酶抑制剂,IC50 为 5.84 uM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥437 有现货
5MG ¥794 有现货
10MG ¥1061 有现货
25MG ¥2049 有现货
50MG ¥3572 有现货
100MG ¥5257 有现货
500MG ¥11259 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    MI-2
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    MI-2(MALT1 抑制剂)是一种选择性、不可逆的 MALT1 副半胱天冬酶抑制剂,IC50 为 5.84 uM。
  • 产品描述
    MI-2 (MALT1 inhibitor) is a selective, irreversible MALT1 paracaspase inhibitor with IC50 of 5.84 uM, displays little activity against the related caspase family members caspase-3, -8, and -9; inhibits cleavage of MALT1 substrates, which is accompanied by NF-κB reporter activity suppression, c-REL nuclear localization inhibition, and NF-κB target gene downregulation; specifically suppress ABC-DLBCL in vitro and in vivo, exhibits GI 50 of 0.2, 0.5, 0.4, and 0.4 uM for HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells respectively, inhibits nuclear translocation of RelB and p50, and decreases Bcl-xL levels in CLL cells.
  • 体外实验
    MALT1 inhibitor MI-2 (1-1000 nM; 48 hours) selectively suppresses MALT1-dependent DLBCL cell lines, and the GI50 in HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells is 0.2, 0.5, 0.4, and 0.4 μM, respectively.MALT1 inhibitor MI-2 (62-1000 nM; 24 hours) causes a dose-dependent decrease in MALT1-mediated cleavage. Cell Proliferation Assay Cell Line:HBL-1, TMD8, OCI-Ly3, OCI-Ly10 cells Concentration:1, 10, 100, 1000 nM Incubation Time:48 hours Result:The GI50 in HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells was 0.2, 0.5, 0.4, and 0.4 μM, respectively.Western Blot Analysis Cell Line:HBL-1 cells Concentration:62, 125, 250, 500, 1000 nM Incubation Time:24 hours Result:Inhibits MALT1 cleavage of CYLD in HBL-1 cells.
  • 体内实验
    MALT1 inhibitor MI-2 (25 mg/kg; i.p.; daily for 14 days) profoundly suppresses the growth of both the TMD8 and HBL-1 ABC-DLBCL xenografts. Animal Model:Eight-week-old male SCID NOD (bearing HBL-1 and TMD8 cells) Dosage:25 mg/kg Administration:Intraperitoneal injection; daily for 14 days Result:Profoundly suppressed the growth of both the TMD8 and HBL-1 ABC-DLBCL xenografts versus vehicle.
  • 同义词
    MI 2 | MI2
  • 通路
    NF-κB
  • 靶点
    MALT1
  • 受体
    MALT1
  • 研究领域
    Inflammation/Immunology
  • 适应症
    ——

化学信息

  • CAS Number
    1047953-91-2
  • 分子量
    455.7223
  • 分子式
    C19H17Cl3N4O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: ≥ 46 mg/mL
  • SMILES
    O=C(NC1=CC=C(N2N=C(OCCOC)N=C2C3=CC=C(Cl)C(Cl)=C3)C=C1)CCl
  • 化学全称
    Acetamide, 2-chloro-N-[4-[5-(3,4-dichlorophenyl)-3-(2-methoxyethoxy)-1H-1,2,4-triazol-1-yl]phenyl]-

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Fontan L, et al. Cancer Cell. 2012 Dec 11;22(6):812-24. 2. Saba NS, et al. Cancer Res. 2017 Dec 15;77(24):7038-7048. 3. Liu W, et al. Oncotarget. 2016 May 24;7(21):30536-49. 4. Yeh CN, et al. Oncotarget. 2017 Dec 8;8(69):113444-113459.
产品手册
关联产品
  • Mepazine hydrochlori...

    Mepazine hydrochloride (Pecazine hydrochloride) 是一种有效的选择性 MALT1 蛋白酶抑制剂。Mepazine hydrochloride 抑制全长 GSTMALT1 和 GSTMALT1 325-760 段的IC50 分别为 0.83 和 0.42 μM。Mepazine hydrochloride 通过增强细胞凋亡 (apoptosis) 来影响 ABC-DLBCL 细胞的生存能力。

  • JNJ-67856633

    JNJ-67856633 是一种口服活性、一流的、有效的、选择性的变构 MALT1 蛋白酶抑制剂。 JNJ-67856633在某些情况下会导致肿瘤瘀滞。

  • MLT943

    MLT-943 是一种有效的、选择性的、具有口服活性的 MALT1 蛋白酶抑制剂。